Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050

When to Start Antiretroviral Therapy in Resource-Limited Settings

(2013) Rochelle P. Walensky   ANNALS OF INTERNAL MEDICINE

The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda

(2012) Elliot Marseille et al.   Applied Health Economics and Health Policy

Towards an improved investment approach for an effective response to HIV/AIDS

(2011) Bernhard Schwartländer et al.   LANCET

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Impact of the New WHO Antiretroviral Treatment Guidelines on HIV Epidemic Dynamics and Cost in South Africa

(2011) Jan A. C. Hontelez et al.   PLoS One

Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries

(2011) Stephen Resch et al.   PLoS One

The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data

(2011) Sydney Rosen et al.   Journal of the International AIDS Society

Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics

(2010) Kartik K Venkatesh et al.   AIDS

HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men

(2010) Philip Rieder et al.   AIDS

Weighing the gold in the gold standard: challenges in HIV prevention research

(2010) Nancy S Padian et al.   AIDS

Expanding access to HAART: a cost-effective approach for treating and preventing HIV

(2010) Karissa M Johnston et al.   AIDS

Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings

(2010) Peter J Dodd et al.   AIDS

Special Anniversary Review: Twenty-five years of human immunodeficiency virus research: successes and challenges

(2010) R. A. Weiss   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa

(2010) Rochelle P Walensky et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs

(2010) Charles B. Holmes   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31

(2010) Robert Hecht et al.   LANCET

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis

(2010) Deborah Donnell et al.   LANCET

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco

(2010) Moupali Das et al.   PLoS One

Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco

(2010) R. J. Smith et al.   SCIENCE

Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review

(2010) Matthew P. Fox et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

The cost of treatment and care for people living with HIV infection: implications of published studies, 1999–2008

(2010) Eduard J Beck et al.   Current Opinion in HIV and AIDS

Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis

(2010) Rochelle P. Walensky et al.   PLOS MEDICINE

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis

(2009) Suzanna Attia et al.   AIDS

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

(2009) Stephen D Lawn et al.   AIDS

The costs and effectiveness of four HIV counseling and testing strategies in Uganda

(2009) Nick Menzies et al.   AIDS

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

(2009)   AIDS

Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance Detection

(2009) Vikram S. Gill et al.   CLINICAL INFECTIOUS DISEASES

Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic

(2009) Robert Hecht et al.   HEALTH AFFAIRS

Male Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making?

(2009)   PLOS MEDICINE

Scaling Up Antiretroviral Therapy in South Africa: The Impact of Speed on Survival

(2008) Rochelle P. Walensky et al.   JOURNAL OF INFECTIOUS DISEASES

Modeling the joint epidemics of TB and HIV in a South African township

(2008) Nicolas Bacaër et al.   JOURNAL OF MATHEMATICAL BIOLOGY

Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study

(2008) Jonathan Mermin et al.   LANCET

New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data

(2008) Kristin L Dunkle et al.   LANCET

Treating our way out of the HIV pandemic: could we, would we, should we?

(2008) Geoffrey P Garnett et al.   LANCET

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

(2008) Reuben M Granich et al.   LANCET

Reassessing HIV Prevention

(2008) M. Potts et al.   SCIENCE

The Great Funding Surge

(2008) J. Cohen   SCIENCE